Gastrointestinal Cancer CALGB 80702

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.